Skip to Content
Merck
All Photos(1)

Key Documents

View All Documentation

SML3415

Sigma-Aldrich

HBX 41,108

≥98% (HPLC)

Synonym(s):

7-Chloro-9-oxo-9H-indeno[1,2-b]pyrazine-2,3-dicarbonitrile, HBX 41108, HBX-41108, HBX41108

Sign Into View Organizational & Contract Pricing
All Photos(1)

About This Item

Empirical Formula (Hill Notation):
C13H3ClN4O
CAS Number:
924296-39-9
Molecular Weight:
266.64
MDL number:
MFCD16251537
UNSPSC Code:
12352200
NACRES:
NA.77

Quality Level

100

Assay

≥98% (HPLC)

form

powder

color

white to beige

solubility

DMSO: 2 mg/mL, clear

storage temp.

2-8°C

SMILES string

O=C(C1=C2C=CC(Cl)=C1)C3=C2N=C(C(C#N)=N3)C#N

InChI

1S/C13H3ClN4O/c14-6-1-2-7-8(3-6)13(19)12-11(7)17-9(4-15)10(5-16)18-12/h1-3H

InChI key

BIGPXXAUSQLTQR-UHFFFAOYSA-N

Biochem/physiol Actions

Catalytic site-targeting, uncompetitive, potent and reversible ubiquitin-specific protease USP7 inhibitor.
HBX 41,108 is a catalytic site-targeting, uncompetitive, potent and reversible ubiquitin-specific protease (USP) inhibitor (USP7/HAUSP IC50 = 420 nM) with little potency toward aspartic, serine or other non-USP cysteine proteases. HBX 41,108 exhibits antiproliferation potency in cancer cultures (HCT116 GI50 = 1 μM post 24 h treatment) by preventing USP7-mediated p53 deubiquitination and thereby promoting p53 target genes expression and inducing p53-dependent apoptosis.

Storage Class Code

11 - Combustible Solids

WGK

WGK 3

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our Documents section.

If you need assistance, please contact Customer Support

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

USP7 regulates the proliferation and differentiation of ATDC5 cells through the Sox9-PTHrP-PTH1R axis.
Dong X, Xu X, Yang C, Luo Y, Wu Y, Wang J
Bone, 143, 115714-115714 (2021)
Hannah B L Jones et al.
Frontiers in chemistry, 9, 640105-640105 (2021-03-16)
The potency and selectivity of a small molecule inhibitor are key parameters to assess during the early stages of drug discovery. In particular, it is very informative for characterizing compounds in a relevant cellular context in order to reveal potential

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service